Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION
Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic
symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.
Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic
symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.
Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic
symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.
Breast implants are not lifetime devices. The longer patients have them, the greater the chance they will develop complications, which may require more surgery. Breast implants have been associated with a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). Some patients have died from BIA-ALCL. Patients have also reported a variety of systemic
symptoms such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others.
The head of the French company responsible for the PIP breast implant was just convicted by a French court and sentence to 4 years in jail for knowingly using sub-standard silicone in his implants. This sentence sends a strong message to the medical device world that regulation is key and that patients deserve tried and tested products that are safe.
